 |
|
Improving quality of life for brain tumour patients
April 22, 2008A new neuroimaging study at the Montreal Neurological Institute and Hospital at McGill University aims to ensure the highest quality of life for patients by assessing their cognitive skills before, during, and after brain tumour surgery. This is done by mapping the important functional brain areas surrounding the tumour in order to decrease the risks during surgery.
Brain tumour surgery requires a delicate balance between removing as much of a tumour as possible in order to ensure a patients' survival and extend life expectancy, while striving to preserve motor, sensory, and cognitive abilities (functional areas of the brain), and thus quality of life. This new study by researchers at the Montreal Neurological Institute and Hospital, published recently in the Journal of Neurosurgery, looks at functional neuroimaging in patients undergoing surgery for the removal of brain tumours. This is done in order to localize important functional areas of the brain so that these can be preserved during the surgical procedure. Functional magnetic resonance imaging (fMRI) has been used extensively to map sensory and motor functions, as well as to define brain regions involved in language processes but, until now, has not been applied to higher-order cognitive functions such as memory. Patients with brain tumours can lead active lives for extended periods following surgery and it is therefore important to consider the preservation of cognitive functions that depend on brain regions close to the tumour in order to maintain the patients' autonomy, and a good postoperative quality of life.
"To the best of our knowledge, this is the first published report applying fMRI to higher cortical processing for the pre-operative evaluation of patients with brain tumours," says Dr. Rolando Del Maestro, Director of the Montreal Neurological Institute's Brain Tumour Research Centre and a lead investigator in the study. Cognitive functions are essential for daily life. For instance, a correct response at a traffic light depends on the selection of possible actions based on previously acquired information and rules. In this situation, for example, green means go and red means stop. Damage to brain areas responsible for this cognitive ability can have a profound affect on the ability of the patient to lead a normal life. Other higher-order cognitive functions include keeping track of information in working memory, or selectively retrieving information from memory - these abilities are associated with the frontal cortex, and are incredibly important for normal functioning in many activities in basic life.
While in the fMRI scanner, pre-operative brain tumour patients are asked to complete a task which assesses the function of the dorsal premotor cortex by requiring them to select between competing actions based on conditional rules. This preoperative fMRI data is then integrated into an image-guided neuronavigation system, which guides neurosurgeons during surgery optimizing the approach for tumour removal in patients and preserving relevant functional regions in the premotor cortical region of the brain.
Patients then undergo post-operative structural MR imaging to show that the resection of the tumour was optimal and that the functional region within the brain's premotor cortex that was involved in the performance of the cognitive task was preserved. Patients in this study showed no deficits in their performance of the task postoperatively, further demonstrating that this specific cognitive function was not altered.
"These preliminary results are promising and suggest that preoperative fMRI is an important tool to assist neurosurgeons in preserving cognitive function in patients who are undergoing brain tumour surgery", stated Dr. Del Maestro. Dr. Del Maestro and his colleagues have also begun intraoperative testing in certain patients, allowing the surgical team to continually monitor and preserve cognitive function at risk during the operation.
This study introduces a new fMRI paradigm to reliably localize and evaluate the cognitive selection of actions in patients with tumours near the dorsal premotor cortex. These techniques are now being applied to assess a broader range of cognitive functions in order to benefit patients with tumours in other brain regions.
The Montreal Neurological Institute
While in the fMRI scanner, pre-operative brain tumour patients are asked to complete a task which assesses the function of the dorsal premotor cortex by requiring them to select between competing actions based on conditional rules. This preoperative fMRI data is then integrated into an image-guided neuronavigation system, which guides neurosurgeons during surgery optimizing the approach for tumour removal in patients and preserving relevant functional regions in the premotor cortical region of the brain.
Patients then undergo post-operative structural MR imaging to show that the resection of the tumour was optimal and that the functional region within the brain's premotor cortex that was involved in the performance of the cognitive task was preserved. Patients in this study showed no deficits in their performance of the task postoperatively, further demonstrating that this specific cognitive function was not altered.
"These preliminary results are promising and suggest that preoperative fMRI is an important tool to assist neurosurgeons in preserving cognitive function in patients who are undergoing brain tumour surgery", stated Dr. Del Maestro. Dr. Del Maestro and his colleagues have also begun intraoperative testing in certain patients, allowing the surgical team to continually monitor and preserve cognitive function at risk during the operation.
This study introduces a new fMRI paradigm to reliably localize and evaluate the cognitive selection of actions in patients with tumours near the dorsal premotor cortex. These techniques are now being applied to assess a broader range of cognitive functions in order to benefit patients with tumours in other brain regions.
The Montreal Neurological Institute
Brain Tumour Current Events and Brain Tumour News RSSCancer cells with a long breath: seeking the origin of brain tumors in children
Medulloblastoma is one of the most common and most malignant brain tumours among children and teenagers. These tumours grow very rapidly, and fifty percent of patients in the long term die from the condition.
Cancer cells spread by releasing 'bubbles', according to an MUHC study
A new fundamental mechanism of how tumour cells communicate has just been discovered by the team of Dr. Janusz Rak at the Research Institute of the McGill University Health Centre (MUHC) in collaboration with Dr Guha from the University of Toronto.
A new radiation therapy treatment developed for head and neck cancer patients
Most head-and-neck cancers that recur locally after prior full-dose conventional radiation therapy respond to Boron Neutron Capture Therapy (BNCT).
Better treatment for children with brain cancer
Young children diagnosed with a malignant type of brain tumour will benefit from research that has taken twelve years to complete.
ew cancer-fighting virus kills invasive brain cells
Researchers funded by The Terry Fox Foundation and the Canadian Cancer Society have found that a cancer-fighting virus called VSV kills the most malignant form of brain cancer in mice.
Cancer researchers confirm brain tumor genetic subtype informs treatment, predicts outcome
Research confirms that determining the genetic composition of brain cancers can better inform doctors and patients for treatment options and prognosis. The findings could change the future of how cancers are diagnosed.
Mobile phone use not linked to increased risk of glioma brain tumours
Mobile phones are not associated with an increased risk of the most common type of brain tumour, finds the first UK study of the relationship between mobile phone use and risk of glioma.
Infections are a major cause of childhood cancer, study suggests
Results from a new study of childhood cancer statistics provide further evidence that common infections affecting mother and baby could play a key role in triggering certain types of the disease.
Gene therapy improves gemcitabine effects in experimental glioma model
ttempts to improve the chemotherapeutic efficacy and radiotherapy-sensitivity of the anticancer agent, gemcitabine, using gene therapy have yielded interesting results in preclinical glioma models presented at the 13th European Cancer Conference (ECCO).
Health: Improving the recognition of brain tumours
Researchers at the Institute of Nuclear Chemistry in Jülich have developed a short-lived, radioactive amino acid that delivers much more precise information on brain tumours and their structure than was possible in the past. By combining positron emission tomography (PET), a process that visualises the spread of radioactive substances in the body, and another method, Helmholtz brain researchers in Jülich and at the University Hospital Düsseldorf can actually diagnose brain tumours with 97% probability. They do this by combining the new method with magnetic resonance spectroscopy (MRS). When both methods indicate a pathological result, the examining doctors can be certain that
More Brain Tumour Current Events and Brain Tumour News Articles
 | On a Wing and a Prayer: Surviving a Brain Tumour by Cameron Fulljames In stark, personal detail, Cameron Fulljames tells the story of his diagnosis of, fight against, and victory over cancer. Assembled from his diaries and written throughout the experience, this book documents the career he had to put on hold and the challenge he and his doctors had before them: a tumor that covered nearly one-fourth of his brain. Faced with the nightmares that accompany a brain... |
| Tumours of the Brain & Skull by George W. Bruyn, Pierre J. Vinken | |
 | Application of independent component analysis to ^1H MR spectroscopic imaging exams of brain tumours [An article from: Analytica Chimica Acta] by F. Szabo de Edelenyi, A.W. Simonetti, G. Postma, H This digital document is a journal article from Analytica Chimica Acta, published by Elsevier in . The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.Description: The low spatial resolution of clinical ^1H MRSI leads to partial volume effects. To overcome this problem, we applied independent... |
 | Palliative Care Consultations in Primary and Metastatic Brain Tumours (Palliative Care Consultations) This is the third book in a new international, multi-contributed series aimed at providing practical, clinical guidance on how to deal with difficult symptoms related to specific cancer sites. There are few more distressing problems for patients and families than the development of a primary or secondary brain tumor. Treatment is often palliative, though intensive, from the start. Little firm... |
| Eye Symptoms in Brain Tumours by A. Huber, F.C. Blodi | |
| Tumours of the brain and skull (Handbook of clinical neurology) by P. J Vinken | |
| Eye Signs and Symptoms in Brain Tumours by Alfred Huber | |
| Drug Delivery in Cancer Treatment III: Home Care Symptom Control, Economy, Brain Tumours (Eso Monographs (European School of Oncology)) | |
| Brain tumours: Scientific basis, clinical investigation and current therapy | |
| Dynamic Factors in Diagnosis of Supratentorial Brain Tumours by Cerebral Angiography by Norman E Leeds, Juan M Taveras |
| © 2008 BrightSurf.com |